Showing results (71-80 of 920) with videos related to
Sort By:
Pageof 92
Hepatology International|January 16, 2022
Predictive performance and clinical utility of HCC risk scores in chronic hepatitis C: a comparative studyGamal Shiha, Nabiel N H Mikhail, Reham Soliman, et al.Therapeutic Advances in Endocrinology and Metabolism|December 29, 2025
GLP-1 receptor agonists and gallbladder disease risk: insights into molecular mechanisms and clinical implicationsMariana M Ramírez-Mejía, Guadalupe Ponciano-Rodriguez, Mohammed Eslam, et al.Thescientificworldjournal|May 5, 2005
Transient hydroureteronephrosis caused by a Foley's catheter tip in the right ureterJacob George, George TharionMolecular Pharmaceutics|December 13, 2007
Nonalcoholic fatty liver disease: pathogenesis and potential for nuclear receptors as therapeutic targetsJacob George, Christopher LiddleJournal of Colloid and Interface Science|December 14, 2004
Intermediate colloidal formation and the varying width of periodic precipitation bands in reaction-diffusion systemsJacob George, George VargheseExpert Review of Vaccines|October 16, 2004
Antigen-tailored therapy based on the inflammatory theory of atherosclerosisDror Harats, Jacob GeorgeNature Genetics|January 30, 2013
Loss of function of the new interferon IFN-λ4 may confer protection from hepatitis CDavid Booth, Jacob GeorgeThe British Journal of Cardiology|July 17, 2026
A follow-up analysis of PCSK9 inhibition therapy in real-world practice: evaluating the efficacy of inclisiranPrashasthi Devaiah, Jacob GeorgeTherapeutics and Clinical Risk Management|October 24, 2009
The role of urate and xanthine oxidase in vascular oxidative stress: future directionsJacob George, Allan StruthersNature Reviews. Gastroenterology & Hepatology|December 2, 2010
Animal models of nonalcoholic fatty liver diseaseLionel Hebbard, Jacob GeorgePageof 92